Literature DB >> 8136305

Modulation of calcium signaling and LH secretion by progesterone in pituitary gonadotrophs and clonal pituitary cells.

O Ortmann1, F Merelli, S S Stojilkovic, K D Schulz, G Emons, K J Catt.   

Abstract

In estradiol-treated pituitary cells, progesterone enhances gonadotropin-releasing hormone (GnRH)-induced LH secretion from cultured rat pituitary cells during short-term treatment but attenuates this response during prolonged treatment. In the present study, the effects of gonadal steroids on GnRH-induced cytoplasmic calcium ([Ca2+]i) responses in gonadotrophs were analyzed in rat pituitary cells and immortalized (alpha T3-1) murine gonadotrophs. Ca2+ responses were measured in cell suspensions and single gonadotrophs, loaded with Fura-2 or Indo-1, respectively, and pretreated for 48 h with 1 nM estradiol with or without 100 nM progesterone, or for 48 h with 1 nM estradiol and then for 3 h with 100 nM progesterone. In cells of the alpha T3-1 gonadotroph lineage, GnRH elicited biphasic Ca2+ signals composed of an initial peak response followed by a prolonged plateau phase. The amplitudes of both the extracellular Ca(2+)-independent spike phase and the extracellular Ca(2+)-dependent plateau phase were enhanced or inhibited by short- or long-term progesterone treatment, respectively. In single pituitary gonadotrophs, GnRH (0.5 nM) elicited oscillatory responses due to intermittent release and uptake of Ca2+ from intracellular stores. Treatment with progesterone shifted the oscillatory signal toward biphasic (3 h) or subthreshold (48 h) response profiles, revealing a steroid-induced change in the pattern of Ca2+ mobilization. In addition to these agonist-induced responses, the transient [Ca2+]i responses of pituitary cells and individual gonadotrophs to high K+ were enhanced or inhibited after short- or long-term progesterone treatment, respectively. These actions were correlated with the effects of progesterone on K(+)-induced LH secretion. The [Ca2+]i and LH secretory responses to phorbol ester treatment were also enhanced by short-term exposure of the cells to progesterone. The results demonstrate that the stimulatory and inhibitory effects of progesterone on agonist-induced Ca2+ signaling result from changes in Ca2+ mobilization and entry, and contribute to the modulatory actions of the steroid on GnRH-induced LH secretion.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8136305     DOI: 10.1016/0960-0760(94)90249-6

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  5 in total

1.  Regulation of GnRH I receptor gene expression by the GnRH agonist triptorelin, estradiol, and progesterone in the gonadotroph-derived cell line alphaT3-1.

Authors:  J M Weiss; S Polack; O Treeck; K Diedrich; O Ortmann
Journal:  Endocrine       Date:  2006-08       Impact factor: 3.633

Review 2.  Brain sexual differentiation and gonadotropins secretion in the rat.

Authors:  D Becú-Villalobos; A González Iglesias; G Díaz-Torga; P Hockl; C Libertun
Journal:  Cell Mol Neurobiol       Date:  1997-12       Impact factor: 5.046

3.  Effects of progesterone (P) and antiprogestin RU486 on LH and FSH release by incubated pituitaries from rats treated with the SERM LY11701 8-HCl and/or recombinant human FSH.

Authors:  C Bellido; R Aguilar; J C Garrido-Gracia; J E Sánchez-Criado
Journal:  J Endocrinol Invest       Date:  2002-09       Impact factor: 4.256

4.  Ontogenic and sexual differences in pituitary GnRH receptors and intracellular Ca2+ mobilization induced by GnRH.

Authors:  I M Lacau-Mengido; A González Iglesias; V Lux-Lantos; C Libertun; D Becú-Villalobos
Journal:  Endocrine       Date:  1998-04       Impact factor: 3.633

Review 5.  GnRH-Induced Ca(2+) Signaling Patterns and Gonadotropin Secretion in Pituitary Gonadotrophs. Functional Adaptations to Both Ordinary and Extraordinary Physiological Demands.

Authors:  Maria Luisa Durán-Pastén; Tatiana Fiordelisio
Journal:  Front Endocrinol (Lausanne)       Date:  2013-09-30       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.